Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.26.9 (
ribonuclease
)
6,589
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The binding of
Coomassie Brilliant Blue R-250
to several species of bovine pancreatic ribonuclease is affected by the presence of a carbohydrate moiety in the enzyme molecule. Enzymic deglycosylation of several chromatographic fractions of
ribonuclease
, which have different degrees of glycosylation, results in increased staining by
Coomassie Brilliant Blue R-250
. Ovalbumin and other glycoproteins tested show similar behavior. The results indicate that carbohydrate moieties may represent a common hindrance to the binding of Coomassie Brilliant Blue dyes to glycoproteins.
...
PMID:Interference of the carbohydrate moiety in coomassie brilliant blue R-250 protein staining. 247 58
Phenol has been added to the
Coomassie Brilliant Blue G
-250 dye reagent used in the standard Bradford protein assay and its effect upon the reagent blank and assay response of fourteen proteins investigated. Phenol can enhance or impair colour yield depending upon its concentration and the amount and type of protein assayed. Four characteristic protein responses to increasing assay concentrations of phenol have been observed. These indicate a complex influence of phenol upon the protein assay. Dye reagent containing 0.5% phenol gave optimal colour yield with most of the proteins investigated and an improved assay response of ovalbumin,
ribonuclease
, lysozyme, insulin, pepsin and chymotrypsinogen-A relative to bovine albumin.
...
PMID:Phenol addition to the Bradford dye binding assay improves sensitivity and gives a characteristic response with different proteins. 378 18